|
Advisory Committee on Blood Safety and AvailabilityPresentations - May 2005
Review of May 2005 Advisory Committee Recommendations
Progress and Challenges in the Efficacy, Safety and Paths to Licensure
Update on IgIV Supply and Reimbursement
IgIV Supply and Reimbursement
Immune Deficiency Foundation
HHS Pandemic Action
National Association of County and City Health Officials
Association of State and Territorial Health Officials
Council of State and Territorial Epidemiologist
Models for Disease Reporting and Adverse Event Surveillance UDC
National Hospital-based Transfusion Reaction Surveillance using the NHSN
Models for Disease Reporting and Adverse Event Surveillance ArborNet
FDA Surveillance Programs
NHLBI's funded RED-II Program: Understanding the RED-II Program and its Role in Detecting Emerging Threats
Orphan Test Development: Removal of TSE Infectivity from Blood and Blood Products by Absorption
PrP-Sc Detection in Blood
Detection of Protein Conformational Disorders
Status of Pathogen Reduction
Orphan Test Development: Malaria Detection
Chagas, Leishmania, and Bioterror Agents
Application of Nanotechnology
Detection of New Pathogens Through Surveillance of Bank Sample
Update from Gambro BCT
Update form Pall
Comments from FDA
Public Comments |
Last Revised: July 14, 2005